In 2024, AbbVie’s presentation at the conference focused on its recent acquisitions of ImmunoGen and Cerevel. AbbVie paid ...
A new CRISPR approach can control genes without cutting DNA, opening a safer path for treating genetic diseases. A newly ...
Immune checkpoint inhibitors (ICIs) have revolutionized cancer therapy by harnessing the body's immune system to target ...
Three start-ups are aiming to create gene-edited babies. Columnist Michael Le Page has no doubt that editing our offspring ...
3dOpinion
The therapy for the future
Explore the potential of gene therapy as a groundbreaking approach to curing diseases, beyond traditional pharmacological ...
Researchers at the Johns Hopkins Kimmel Cancer Center's Ludwig Center developed a new treatment that selectively targets ...
Researchers identify stem cell–based molecular subtypes that improve prognosis prediction in colorectal cancer and support ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback